DeprEpil Study
CRF version 1.0 of 04/03/2020
Protocol DeprEpil
Clinical Phase: Phase IV
EFFECTS OF ANTIDEPRESSANT TREATMENT WITH AGOMELATINE ON PATIENTS AFFECTED BY DEPRESSION AND EPILEPSY. A DOUBLE BLIND RANDOMIZED STUDY WITH ACTIVE CONTROL (ESCITALOPRAM) WITH PARALLEL GROUPS.
Copyright © 2020 LNAGE S.R.L. - TUTTI I DIRITTI RISERVATI
per contatti riguardanti lo Studio DeprEpil
DeprEpil@lnage.it